MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Aguettant Sodium Valproate | |
New | Amcal Prochlorperazine | |
New | APOHealth Promethazine Allergy Relief | |
New | APX-Metformin | |
New | ATO Mepivacaine 3% | |
New | Bortezomib Accord | |
New | Candacort MiniPak | |
New | Chemists' Own Antihistamine for Allergy Relief | |
New | Deferasirox Sandoz | |
New | Flucloxacillin Kabi | |
New | Fluzone High-Dose Quadrivalent | |
New | Fulvestrant Ever Pharma | |
New | Gastro-Stop Plus | |
New | Inflamax Liquid Caps 25 | |
New | Methylphenidate-Teva XR | |
New | Oxycodone-hameln | |
New | Oxyndone | |
New | PEA 600 | |
New | Pharmacor Dimethyl Fumarate | |
New | Pharmacy Care Prochlorperazine | |
New | Qarziba | |
New | Rocuronium Bromide Medsurge | |
New | Vitrakvi | |
New | Zolgensma | |
Revised | Actos | TGA Date |
Revised | Adacel | Dose and Method of Administration, Special Precautions for Storage |
Revised | ADT Booster | Adverse Effects (Undesirable Effects), Incompatibilities, Pharmaceutical Form |
Revised | Allersoothe | Contraindications, Dose and Method of Administration, List of Excipients, Pharmaceutical Form, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Allersoothe Elixir | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Indications, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Alphaclav Duo 500/125, Alphaclav Duo Forte 875/125 | TGA Date |
Revised | Angeliq 1/2 | Special Warnings and Precautions for Use |
Revised | APO-Clotrimazole 3 and 6 Day Cream | Fertility, Pregnancy and Lactation, Sponsor |
Revised | APO-Mebeverine | TGA Date |
Revised | APO-Mycophenolate Capsules | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Precautions for Disposal |
Revised | APO-Piroxicam | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | APX-Citalopram | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | APX-Paracetamol/Codeine | Adverse Effects (Undesirable Effects) |
Revised | APX-Quetiapine XR | TGA Date |
Revised | Azep Nasal Spray | Special Precautions for Storage |
Revised | Baxter Heparin Sodium in 0.9% Sodium Chloride | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | BiCNU | TGA Date |
Revised | Cablivi | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Chemists' Own Femazole Duo | Product Name change |
Revised | Chemists' Own Sinus + Pain Relief | Product Name change |
Revised | Cinacalcet Mylan | Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Physicochemical Properties |
Revised | Citalopram Sandoz | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Climara | Special Warnings and Precautions for Use |
Revised | Clozaril | Nature and Contents of Container |
Revised | Comirnaty | Adverse Effects (Undesirable Effects) |
Revised | Comirnaty (Tris/Sucrose Presentation) | Adverse Effects (Undesirable Effects) |
Revised | Condyline Paint | TGA Date |
Revised | Coregas Medical Air | Dose and Method of Administration, Nature and Contents of Container |
Revised | Coregas Medical Carbon Dioxide | Dose and Method of Administration, Nature and Contents of Container |
Revised | Darzalex | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Darzalex SC | Adverse Effects (Undesirable Effects) |
Revised | DBL Cytarabine 1 g/10 mL Injection | Dose and Method of Administration, Dose and Method of Administration, Incompatibilities, Incompatibilities, Pharmacological Properties, Pharmacological Properties, Special Warnings and Precautions for Use, Special Warnings and Precautions for Use |
Revised | DBL Cytarabine 2 g/20 mL Injection | Dose and Method of Administration, Dose and Method of Administration, Incompatibilities, Incompatibilities, Pharmacological Properties, Pharmacological Properties, Special Warnings and Precautions for Use, Special Warnings and Precautions for Use |
Revised | Dithiazide | Adverse Effects (Undesirable Effects) |
Revised | Elovax One Dose | Nature and Contents of Container |
Revised | Entocort | TGA Date |
Revised | Epilim | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Epilim IV | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Equanox | Nature and Contents of Container |
Revised | Esipram | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ezetimibe GH | New indication, Pharmacological Properties |
Revised | Fasturtec | Deleted Presentation, Dose and Method of Administration, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Feldene, Feldene-D | Adverse Effects (Undesirable Effects), Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Fluarix Tetra | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Fluconazole Sandoz | Contraindications, Special Warnings and Precautions for Use |
Revised | Fluconazole Sandoz Injection | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Fluotex | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | FluQuadri | Qualitative and Quantitative Composition |
Revised | Genox | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Imatinib-Teva | TGA Date |
Revised | Influvac Tetra | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Jardiance | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, New indication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Jorveza | TGA Date |
Revised | Lansoprazole ODT GH | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lexam | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Lipigem | Pharmaceutical Form |
Revised | Lorviqua | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | MabCampath | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Marcain, Marcain with Adrenaline | Nature and Contents of Container |
Revised | Metformin GH | Pharmaceutical Form |
Revised | Metomax | Nature and Contents of Container |
Revised | Mylotarg | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Precautions for Storage |
Revised | Navelbine | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Nitrolingual Pumpspray | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Overdose, Special Warnings and Precautions for Use |
Revised | NovoMix | TGA Date |
Revised | NovoRapid | TGA Date |
Revised | Ofev | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Olanzapine ODT Generichealth | Nature and Contents of Container |
Revised | Optisulin | Dose and Method of Administration, Nature and Contents of Container, Physicochemical Properties, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage |
Revised | Orencia | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Panamax Co | Adverse Effects (Undesirable Effects) |
Revised | Paracetamol/Codeine GH 500/30 | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Prasugrel SCP | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Prodeine | Adverse Effects (Undesirable Effects) |
Revised | Prodeinextra | Adverse Effects (Undesirable Effects) |
Revised | Progynova | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Quetiapine-AS XR | Adverse Effects (Undesirable Effects), List of Excipients, Overdose, Special Warnings and Precautions for Use |
Revised | Remicade | Adverse Effects (Undesirable Effects) |
Revised | Resprim, Resprim Forte | Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Revatio | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Reyataz | Deleted Presentation |
Revised | Rimycin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ronapreve | Dose and Method of Administration, Shelf Life |
Revised | Sabril | Pharmaceutical Form |
Revised | Salofalk Tablets | Nature and Contents of Container |
Revised | Shingrix | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Therapeutic Indications |
Revised | Snuzaid Tabs | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Sodium Valproate Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Solu-Cortef | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Sudafed Sinus + Anti-inflammatory Pain Relief Caplets | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Synagis | Sponsor, TGA Date |
Revised | Talam | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tarka | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Tramal | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Trelegy Ellipta | Pharmacological Properties |
Revised | Tysabri | TGA Date |
Revised | Valpro EC | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Valproate Winthrop | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Vaxzevria | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Viatocinon | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Vyepti | Special Precautions for Storage |
Revised | Xylocaine and Xylocaine with Adrenaline | Nature and Contents of Container |
Revised | Zempreon CFC-Free Inhaler with Counter | Nature and Contents of Container, Special Precautions for Storage, Sponsor |
Revised | Zentel | Pharmaceutical Form |
Revised | Ziextenzo | TGA Date |
Revised | Zimstat | TGA Date |
Revised | Zonegran | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Sponsor |
Revised | Zumenon | Nature and Contents of Container |
Deleted | DBL Cephalothin Sodium for Injection | |
Deleted | DBL Octreotide Injection | |
Deleted | MabThera | |
Deleted | MabThera SC | |
Deleted | Oxytocin Sandoz | |
Deleted | Valaciclovir SZ |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au